Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1996-03-11
1999-11-02
Housel, James C.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352401, 435243, 4352521, 435260, C12N 500, C12N 100, C12N 112, C12N 104
Patent
active
059768606
ABSTRACT:
The present invention relates, in general, to granulocytic Ehrlichia. In particular, the present invention relates to a cell line selected from the group consisting of a promyelocytic leukemia cell line, an acute myelogenous leukemia cell line, a histiocytic lymphoma cell line, a monocyte macrophage-like cell line, an acute monocytic leukemia cell line, and an embryonic lung cell line wherein the cell line is infected with granulocytic Ehrlichia, a method of continually growing granulocytic Ehrlichia, vaccines comprising granulocytic Ehrlichia or granulocytic Ehrlichia antigens, methods of preventing ehrlichiosis in an animal, antibodies to granulocytic Ehrlichia, and methods for identifying granulocytic Ehrlichia in an animal.
REFERENCES:
patent: 5192679 (1993-03-01), Dawson et al.
Winjum et al "In vitro proliferation of a canine granulocytic Ehrlichia" Veterinary Microbiology, 34 (1993) 355-362.
Anderson, B. E. et al., "Ehrlichia chaffeensis, a New Species Associated with Human Ehrlichiosis," J. Clin. Microbiol. 29(12):2838-2842 (1991).
Bakken, J. S. et al., "Human Granulocytic Ehrlichiosis in the Upper Midwest United States: A New Species Emerging?," J. Amer. Med. Assoc. 272(3):212-218 (Jul. 1994).
Brouqui, P. et al., "Cytopathic Effect, Plaque Formation, and Lysis of Ehrlichia chafeensis Grown on Continuous Cell Lines," Inf. Immun. 62(2):405-411 (Feb. 1994).
Chen, S.-M. et al., "Identification of a Granulocytotropic Ehrlichia Species as the Etiologic Agent of Human Disease," J. Clin. Microbiol. 32(3):589-595 (Mar. 1994).
Collins, S. J. et al., "Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture," Nature 270:347-348 (1977).
Eremeeva, M. et al., "Differentiation among Spotted Fever Group Rickettsiae Species by Analysis of Restriction Fragment Length Polymorphism of PCR-Amplified DNA," J. Clin. Microbiol. 32(3):803-810 (Mar. 1994).
Goodman, J. L. et al., "Direct Cultivation of the Causative Agent of Human Granulocytic Ehrlichiosis," New Eng. J. Med. 334(4):209-215 (Jan. 1996).
Holland, C. J. et al., "Isolation, Experimental Transmission, and Characterization of Causative Agent of Potomac Horse Fever," Science 227:522-524 (1985).
Jongejan, F., "Protective Immunity to Heartwater (Cowdria ruminantium Infection) Is Acquired after Vaccination with In Vitro-Attenuated Rickettsiae," Inf. Immun. 59(2):729-731 (1991).
Kakoma, I. et al., "Cultural, Molecular, and Immunological Characterization of the Etiologic Agent for Atypical Canine Ehrlichiosis," J. Clin. Microbiol. 32(1):170-175 (Jan. 1994).
Lewis, G. E., "Equine Ehrlichiosis: A Comparison between E. equi and Other Pathogenic Species of Ehrlichia," Vet. Parasitol. 2:61-74 (1976).
Mather, T. N. et al., "Competence of dogs as reservoirs for Lyme disease spirochetes (Borrelia burgdorferi)," J. Amer. Vet. Med. Assoc. 205(2):186-188 (Jul. 1994).
Mather, T. N. et al., "Borrelia burgdorferi and Babesia microti: Efficiency of Transmission from Reservoirs to Vector Ticks (Ixodes dammini)," Exp. Parasitol. 70:55-61 (1990).
McDade, J. E., "Ehrlichiosis--A Disease of Animals and Humans," J. Inf. Dis. 161:609-617 (1990).
Palmer, J. E., "Prevention of Potomac Horse Fever," Cornell Vet. 79(3):201-205 (1989).
Rikihisa, Y., "The Tribe Ehrlichieae and Ehrlichial Diseases," Clin. Microbiol. Rev. 4(3):286-308 (1991).
Ristic, M. and D. L. Huxsoll, in Bergey's Manual of Sytematic Bacteriology, Krieg, N. et al., eds., Williams and Wilkins:Baltimore pp. 704-709 (1986).
Rynkiewicz, D. L. et al., "Human Ehrlichiosis in New England," New Eng. J. Med. 330(4):292-293 (Jan. 1994).
Sells, D. M. et al., "Ultrastructural Observations on Ehrlichia equi Organisms in Equine Granulocytes," Inf. Immun. 13(1):273-280 (1976).
Stockham, S. L. et al., "Evaluation of granulocytic ehrlichiosis in dogs of Missouri, including serologic status to Ehrlichia canis, Ehrlichia equi, and Borrelia burgdorferi," Amer. J. Vet. Res. 53(1):63-68 (1992).
Weisburg, W. G. et al., "Phylogenetic Diversity of Rickettsiae," J. Bacteriol. 171(8):4202-4206 (1989).
Weiss, E. et al., "Substrate Utilization by Ehrlichia sennetsu and Ehrlichia risticii Separated from Host Constituents by Renografin Gradient Centrifugation," J. Bacteriol. 170(11):5012-5017 (1988).
Coughlin Richard T.
Gingrich-Baker Cindy
Aquila Biopharmaceuticals Inc.
Housel James C.
Swartz Rodney P.
LandOfFree
Cell lines infected with granulocytic ehrlichia, vaccines, diagn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell lines infected with granulocytic ehrlichia, vaccines, diagn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell lines infected with granulocytic ehrlichia, vaccines, diagn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133665